Genic (A123330) Stock Overview
Researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A123330 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Genic Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩19,660.00 |
| 52 Week High | ₩44,100.00 |
| 52 Week Low | ₩16,000.00 |
| Beta | 1.6 |
| 1 Month Change | -9.61% |
| 3 Month Change | -30.90% |
| 1 Year Change | 14.64% |
| 3 Year Change | 286.25% |
| 5 Year Change | 404.10% |
| Change since IPO | -31.89% |
Recent News & Updates
These 4 Measures Indicate That Genic (KOSDAQ:123330) Is Using Debt Safely
Dec 04
Under The Bonnet, Genic's (KOSDAQ:123330) Returns Look Impressive
Nov 03Recent updates
These 4 Measures Indicate That Genic (KOSDAQ:123330) Is Using Debt Safely
Dec 04Under The Bonnet, Genic's (KOSDAQ:123330) Returns Look Impressive
Nov 03Does Genic (KOSDAQ:123330) Have A Healthy Balance Sheet?
Jul 15A Look At The Fair Value Of Genic Co., Ltd. (KOSDAQ:123330)
Jun 16After Leaping 37% Genic Co., Ltd. (KOSDAQ:123330) Shares Are Not Flying Under The Radar
May 26Genic (KOSDAQ:123330) Is Very Good At Capital Allocation
May 23Risks Still Elevated At These Prices As Genic Co., Ltd. (KOSDAQ:123330) Shares Dive 25%
Apr 09Genic's (KOSDAQ:123330) Earnings Aren't As Good As They Appear
Mar 25Genic (KOSDAQ:123330) Is Experiencing Growth In Returns On Capital
Jan 23Is Genic (KOSDAQ:123330) Using Too Much Debt?
Dec 26Genic Co., Ltd.'s (KOSDAQ:123330) Popularity With Investors Under Threat As Stock Sinks 30%
Nov 29There's Reason For Concern Over Genic Co., Ltd.'s (KOSDAQ:123330) Massive 34% Price Jump
Oct 10Genic Co., Ltd.'s (KOSDAQ:123330) Share Price Not Quite Adding Up
Jul 27Genic Co., Ltd.'s (KOSDAQ:123330) Shareholders Might Be Looking For Exit
Mar 12Genic (KOSDAQ:123330) Is Making Moderate Use Of Debt
Mar 19We Think Genic (KOSDAQ:123330) Has A Fair Chunk Of Debt
Dec 03Shareholder Returns
| A123330 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 4.6% | -0.8% | 4.1% |
| 1Y | 14.6% | 36.1% | 65.5% |
Return vs Industry: A123330 underperformed the KR Personal Products industry which returned 36.1% over the past year.
Return vs Market: A123330 underperformed the KR Market which returned 65.5% over the past year.
Price Volatility
| A123330 volatility | |
|---|---|
| A123330 Average Weekly Movement | 10.1% |
| Personal Products Industry Average Movement | 5.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in KR Market | 11.4% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A123330's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A123330's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 324 | Hyun-ho Yoo | www.genic21.com |
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands.
Genic Co., Ltd. Fundamentals Summary
| A123330 fundamental statistics | |
|---|---|
| Market cap | ₩153.83b |
| Earnings (TTM) | ₩18.30b |
| Revenue (TTM) | ₩85.47b |
Is A123330 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A123330 income statement (TTM) | |
|---|---|
| Revenue | ₩85.47b |
| Cost of Revenue | ₩60.07b |
| Gross Profit | ₩25.40b |
| Other Expenses | ₩7.10b |
| Earnings | ₩18.30b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.34k |
| Gross Margin | 29.72% |
| Net Profit Margin | 21.42% |
| Debt/Equity Ratio | 14.3% |
How did A123330 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/07 16:24 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genic Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eun Jung Park | Daishin Securities Co. Ltd. |
| Na Young Park | Daiwa Securities Co. Ltd. |
| Choi Soon-Ho | Eugene Investment & Securities Co Ltd. |